|
INN ▲
|
ATC Code ▲
|
Country ▲
|
Classification ▲
|
Last update ▼
|
MA Number ▲
|
Registration date ▲
|
Status ▲
|
|
SACCHARATED IRON OXIDE |
B03AB02 |
RO
|
Not authorised
|
21-11-2023 |
|
|
VALID
|
|
VOCLOSPORIN |
L04AD03 |
RO
|
POM
|
21-11-2023 |
EMEA/H/C/005256 |
15-09-2022 |
VALID
|
|
FORMOTEROL, GLYCOPYRRONIUM BROMIDE AND BUDESONIDE |
R03AL11 |
RO
|
POM
|
20-11-2023 |
EMEA/H/C/004983 |
09-12-2020 |
VALID
|
|
TISLELIZUMAB |
L01FF09 |
RO
|
Not authorised
|
20-11-2023 |
|
|
VALID
|
|
ATOGEPANT |
N02CD07 |
RO
|
Not authorised
|
15-11-2023 |
|
|
VALID
|
|
FUTIBATINIB |
L01EN04 |
RO
|
Not authorised
|
15-11-2023 |
|
|
VALID
|
|
GLOFITAMAB |
L01FX28 |
RO
|
List I
|
15-11-2023 |
EMEA/H/C/005751 |
07-07-2023 |
VALID
|
|
IVOSIDENIB |
L01XM02 |
RO
|
List I
|
15-11-2023 |
EMEA/H/C/005936 |
04-05-2023 |
VALID
|
|
MIRIKIZUMAB |
L04AC24 |
RO
|
List I
|
15-11-2023 |
EMEA/H/C/005122 |
26-05-2023 |
VALID
|
|
PEGUNIGALSIDASE ALFA |
A16AB20 |
RO
|
Not authorised
|
15-11-2023 |
|
|
VALID
|
|
PIFLUFOLASTAT (18F) |
V09IX16 |
RO
|
Not authorised
|
15-11-2023 |
|
|
VALID
|
|
RESPIRATORY SYNCYTIAL VIRUS VACCINES |
J07BX05 |
RO
|
List I
|
15-11-2023 |
EMEA/H/C/006027 |
23-08-2023 |
VALID
|
|
RITLECITINIB |
L04AF08 |
RO
|
Not authorised
|
15-11-2023 |
|
|
VALID
|
|
TALQUETAMAB |
L01FX29 |
RO
|
List I
|
15-11-2023 |
EMEA/H/C/005864 |
21-08-2023 |
VALID
|
|
UBLITUXIMAB |
L04AG14 |
RO
|
Not authorised
|
15-11-2023 |
|
|
VALID
|
|
DENGUE VIRUS VACCINES |
J07BX04 |
RO
|
List I
|
03-10-2023 |
EMEA/H/C/005155 |
05-12-2022 |
VALID
|
|
DEUCRAVACITINIB |
L04AF07 |
RO
|
List I
|
03-10-2023 |
EMEA/H/C/005755 |
24-03-2023 |
VALID
|
|
FERRIC OXIDE POLYMALTOSE COMPLEXES |
B03AB05 |
RO
|
List II
|
03-10-2023 |
5852 |
|
VALID
|
|
FERRIC OXIDE POLYMALTOSE COMPLEXES AND FOLIC ACID |
B03AD04 |
RO
|
List II
|
03-10-2023 |
|
|
VALID
|
|
FERROUS FUMARATE AND FOLIC ACID |
B03AD02 |
RO
|
List II
|
03-10-2023 |
|
|
VALID
|
|
FERROUS SULFATE AND FOLIC ACID |
B03AD03 |
RO
|
List II
|
03-10-2023 |
4011 |
09-12-2003 |
VALID
|
|
GALLIUM (68GA) GOZETOTIDE |
V09IX14 |
RO
|
List I
|
03-10-2023 |
EMEA/H/C/005488 |
09-12-2022 |
VALID
|
|
LONCASTUXIMAB TESIRINE |
L01FX22 |
RO
|
List I
|
03-10-2023 |
EMEA/H/C/005685 |
20-12-2022 |
VALID
|
|
LUTETIUM (177LU) VIPIVOTIDE TETRAXETAN |
V10XX05 |
RO
|
List I
|
03-10-2023 |
EMEA/H/C/005483 |
09-12-2022 |
VALID
|
|
MARALIXIBAT CHLORIDE |
A05AX04 |
RO
|
List I
|
03-10-2023 |
EMEA/H/C/005857 |
09-12-2022 |
VALID
|
|
MARIBAVIR |
J05AX10 |
RO
|
List I
|
03-10-2023 |
EMEA/H/C/005787 |
09-11-2022 |
VALID
|
|
MITAPIVAT |
B06AX04 |
RO
|
List I
|
03-10-2023 |
EMEA/H/C/005540 |
09-11-2022 |
VALID
|
|
NIRMATRELVIR AND RITONAVIR |
J05AE30 |
RO
|
List I
|
03-10-2023 |
EMEA/H/C/005973 |
28-01-2022 |
VALID
|
|
NIRSEVIMAB |
J06BD08 |
RO
|
List I
|
03-10-2023 |
EMEA/H/C/005304 |
31-10-2022 |
VALID
|
|
RUXOLITINIB |
D11AH09 |
RO
|
List I
|
03-10-2023 |
EMEA/H/C/005843 |
19-04-2023 |
VALID
|
|
SPESOLIMAB |
L04AC22 |
RO
|
List I
|
03-10-2023 |
EMEA/H/C/005874 |
09-12-2022 |
VALID
|
|
SUTIMLIMAB |
L04AJ04 |
RO
|
List I
|
03-10-2023 |
EMEA/H/C/005776 |
15-11-2022 |
VALID
|
|
TABELECLEUCEL |
L01XL09 |
RO
|
List I
|
03-10-2023 |
EMEA/H/C/004577 |
16-12-2022 |
VALID
|
|
TREMELIMUMAB |
L01FX20 |
RO
|
List I
|
03-10-2023 |
EMEA/H/C/004650 |
20-02-2023 |
VALID
|
|
VARIOUS COMBINATIONS |
B03AE10 |
RO
|
List II
|
03-10-2023 |
3595 |
09-07-2003 |
VALID
|
|
DIOSMIN |
C05CA03 |
RO
|
List II + Exemption
|
21-09-2023 |
5968 |
|
VALID
|
|
BOSENTAN |
C02KX01 |
RO
|
List I
|
06-09-2023 |
|
|
VALID
|
|
BOSUTINIB |
L01EA04 |
RO
|
List I
|
06-09-2023 |
|
|
VALID
|
|
DABRAFENIB |
L01EC02 |
RO
|
List I
|
06-09-2023 |
|
|
VALID
|
|
ERLOTINIB |
L01EB02 |
RO
|
List I
|
06-09-2023 |
|
|
VALID
|
|
ICATIBANT |
B06AC02 |
RO
|
List I
|
06-09-2023 |
|
|
VALID
|
|
NILOTINIB |
L01EA03 |
RO
|
List I
|
06-09-2023 |
|
|
VALID
|
|
PEGASPARGASE |
L01XX24 |
RO
|
List I
|
06-09-2023 |
|
|
VALID
|
|
PERTUZUMAB AND TRASTUZUMAB |
L01FY01 |
RO
|
List I
|
06-09-2023 |
|
|
VALID
|
|
TEMSIROLIMUS |
L01EG01 |
RO
|
List I
|
06-09-2023 |
|
|
VALID
|
|
TOPOTECAN |
L01CE01 |
RO
|
List I
|
06-09-2023 |
|
|
VALID
|
|
VEMURAFENIB |
L01EC01 |
RO
|
List I
|
06-09-2023 |
|
|
VALID
|
|
BARICITINIB |
L04AF02 |
RO
|
List I
|
19-07-2023 |
|
|
VALID
|
|
BUPRENORPHINE, COMBINATIONS |
N07BC51 |
RO
|
List I
|
19-07-2023 |
EMEA/H/C/004407 |
10-11-2017 |
VALID
|
|
COMBINATIONS |
N01BB20 |
RO
|
Not subject to prescription
|
19-07-2023 |
|
|
VALID
|
